News

• Lipoxen Strengthens Management Team - 18 August 2008

• Financial Results for the 12 months ended 31 December 2007 - 26 June 2008

• Canadian EPO Trial Correction - 19 June 2008

• Lipoxen has received approval to conduct the second Phase I trial - 16 June 2008

• Lipoxen receives grant to research improved HIV vaccine delivery - 13 June 2008

• Lipoxen announces positive Phase I data with its long-acting insulin candidate, SuliXen - 29 May 2008

• Lipoxen PLC Presenting at Sachs Associates - 22 April 2008

• Lipoxen Announces Positive Phase I ErepoXen Results - 21 April 2008

• Lipoxen reports further advancement of its DNA vaccine delivery patent portfolio - 17 March 2008

• Lipoxen Completes Technology Transfer for Sustained-Release Insulin - 14 March 2008

Investor news

News archive